Anelis Quintana Cantillo, MSc, holds a bachelor’s degree in biology and a master’s degree in drug technology and control, both from Havana University. Anelis currently...
Wendy Montero Pérez has a bachelor’s degree in pharmaceutical sciences from Havana University. She works in the Department of Quality Assurance at the Center of...
Azalia de la Caridad Rodríguez Taño, MSc, has a bachelor’s degree in biochemistry and molecular biology and a master’s degree in biochemistry, both from Havana...
Olga Lidea Fernandez Saez graduated as a technician in industrial chemistry. Since then, she has worked as a control process analyst in the R&D BioProcess...
Leina Moro Pérez holds a bachelor of science in biochemistry and molecular biology from Havana University. Leina works as Purification Specialist in the R&D BioProcess...
Alexi Bueno Soler is a Chemical Engineer who has worked in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana since...
José Luis Durán graduated as a technician in industrial chemistry. He works on the purification of mAbs and therapeutic vaccines in the R&D BioProcess Development...
Tammy Boggiano Ayo, MSc, has a bachelor of science in radiochemistry and a master of science in biotechnology from Havana University. From 2010 to 2016...
Pharmaceutical manufacturing facilities produce a variety of products, including highly potent products that require safety measures to prevent adverse health effects on patients and operators. To ensure safety, these facilities use containment equipment to minimize the risk of contamination. This article presents criteria for selecting containment equipment, considering both...
The world is beginning to grasp the huge challenge of achieving net-zero carbon emissions, or carbon neutrality, by 2050. Many countries have committed to achieving this ambitious goal. As a major global industry, the pharmaceutical sector has a significant role to play. For thermal energy–intensive industries, such as pharmaceutical manufacturing, the long-term future options to maintain...
As the pharma industry moves to an ambitious Validation 4.0 paradigm, computerized systems play a pivotal role in enabling the rapid transition. Innovation and agility in computerized system validation (CSV) received a strong push in the second half of 2022 with the publication of the FDA draft guidance on “Computer Software Assurance for Production and Quality System Software”